These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 32319728)

  • 1. RGS16 promotes glioma progression and serves as a prognostic factor.
    Huang R; Li G; Zhao Z; Zeng F; Zhang K; Liu Y; Wang K; Hu H
    CNS Neurosci Ther; 2020 Aug; 26(8):791-803. PubMed ID: 32319728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma.
    Sun JZ; Zhang JH; Li JB; Yuan F; Tong LQ; Wang XY; Chen LL; Fan XG; Zhang YM; Ren X; Zhang C; Yu SP; Yang XJ
    Dis Markers; 2021; 2021():6680883. PubMed ID: 34211612
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Qu S; Liu J; Wang H
    Front Immunol; 2021; 12():648416. PubMed ID: 33889156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
    Tian QS; Zhang Q; Huang W
    Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
    Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
    Front Immunol; 2020; 11():603341. PubMed ID: 33363544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of beta-2 microglobulin expression on the survival of glioma patients via modulating the tumor immune microenvironment.
    Tang F; Zhao YH; Zhang Q; Wei W; Tian SF; Li C; Yao J; Wang ZF; Li ZQ
    CNS Neurosci Ther; 2021 Aug; 27(8):951-962. PubMed ID: 33960680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
    Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
    Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CKAP2 expression is associated with glioma tumor growth and acts as a prognostic factor in high‑grade glioma.
    Wang K; Huang R; Li G; Zeng F; Zhao Z; Liu Y; Hu H; Jiang T
    Oncol Rep; 2018 Oct; 40(4):2036-2046. PubMed ID: 30066946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ARL3 is downregulated and acts as a prognostic biomarker in glioma.
    Wang Y; Zhao W; Liu X; Guan G; Zhuang M
    J Transl Med; 2019 Jun; 17(1):210. PubMed ID: 31234870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and Prognostic Role of PANK1 in Glioma.
    Zhao Z; Xu X; Ma S; Li L
    Comb Chem High Throughput Screen; 2024; 27(5):715-724. PubMed ID: 37138430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.
    Cheng W; Li M; Jiang Y; Zhang C; Cai J; Wang K; Wu A
    J Neurosurg; 2016 Jul; 125(1):7-16. PubMed ID: 26544773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.
    Han MZ; Xu R; Xu YY; Zhang X; Ni SL; Huang B; Chen AJ; Wei YZ; Wang S; Li WJ; Zhang Q; Li G; Li XG; Wang J
    J Exp Clin Cancer Res; 2017 Nov; 36(1):155. PubMed ID: 29110682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma.
    Lvu W; Fei X; Chen C; Zhang B
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32725165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAB38 confers a poor prognosis, associated with malignant progression and subtype preference in glioma.
    Wang H; Jiang C
    Oncol Rep; 2013 Nov; 30(5):2350-6. PubMed ID: 24026199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
    Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
    BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA LINC00152 is a potential prognostic biomarker in patients with high-grade glioma.
    Wang W; Wu F; Zhao Z; Wang KY; Huang RY; Wang HY; Lan Q; Wang JF; Zhao JZ
    CNS Neurosci Ther; 2018 Oct; 24(10):957-966. PubMed ID: 29577647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and clinical characterization of TMEM71 expression at the transcriptional level in glioma.
    Wang KY; Huang RY; Tong XZ; Zhang KN; Liu YW; Zeng F; Hu HM; Jiang T
    CNS Neurosci Ther; 2019 Sep; 25(9):965-975. PubMed ID: 31180187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.
    Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X
    Front Immunol; 2022; 13():899710. PubMed ID: 35677036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of CD44 is associated with a poor prognosis in grade II/III gliomas.
    Hou C; Ishi Y; Motegi H; Okamoto M; Ou Y; Chen J; Yamaguchi S
    J Neurooncol; 2019 Nov; 145(2):201-210. PubMed ID: 31506754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of exogenous RGS16 gene transfection on growth of glioma cell line C6].
    Hong L; Li Q; Chen GS; Zhang F; Nie L; Lin SC
    Ai Zheng; 2006 Jan; 25(1):51-5. PubMed ID: 16405749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.